<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>45</viewCount><searchCount>0</searchCount></scores><additional><submitter>King RM</submitter><funding>NINDS NIH HHS</funding><funding>Phenox Gmbh</funding><pagination>1218-1223</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8209672</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>43(8)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>The implantation of flow diverters requires administration of dual anti-platelet therapy, posing the potential for complications. The p48MW HPC (phenox, Bochüm, Germany) hydrophilic-coated flow diverting stent is designed to be anti-thrombotic, thus opening the potential for single anti-platelet therapy. We deploy a novel intravascular high-resolution imaging technique, high-frequency optical coherence tomography (HF-OCT), to study in an animal model the acute thrombus formation on coated p48MW devices versus uncoated control devices.&lt;h4>Methods&lt;/h4>Three pigs were implanted with 4 flow diverters each, two test hydrophilic-coated devices, and two control uncoated devices (p48MW). Each pig was treated with a different anti-platelet regime: no anti-platelet therapy, aspirin only, aspirin and clopidogrel. Twenty minutes after the flow diverter was implanted, an HF-OCT data set was acquired. Acute clot formed on the flow diverter at each covered side branch was measured from the HF-OCT slices. Factors considered to be important were the device type (pHPC versus bare metal), aspirin, clopidogrel, and vessel location. A linear model was constructed from the significant factors.&lt;h4>Results&lt;/h4>Both coating (p &lt; 0.001) and aspirin (p = 0.003) were significantly related to reduction in clot burden, leading to an approximate 100-fold and 50-fold reduction in clot, respectively.&lt;h4>Conclusions&lt;/h4>This study shows the power of HF-OCT not only in the detection of clot but also the quantification of clot burden. In an animal model, the pHPC-coated p48MW significantly reduced acute thrombus formation over jailed side branches as compared to the bare metal p48MW that was nearly eliminated when combined with aspirin administration.</pubmed_abstract><journal>Cardiovascular and interventional radiology</journal><pubmed_title>Acute Thrombus Burden on Coated Flow Diverters Assessed by High Frequency Optical Coherence Tomography.</pubmed_title><pmcid>PMC8209672</pmcid><funding_grant_id>R43 NS100163</funding_grant_id><funding_grant_id>R44 NS100163</funding_grant_id><pubmed_authors>Henkes H</pubmed_authors><pubmed_authors>Gounis MJ</pubmed_authors><pubmed_authors>Puri AS</pubmed_authors><pubmed_authors>Langan ET</pubmed_authors><pubmed_authors>King RM</pubmed_authors><pubmed_authors>Raskett CM</pubmed_authors><pubmed_authors>Ughi GJ</pubmed_authors><view_count>45</view_count></additional><is_claimable>false</is_claimable><name>Acute Thrombus Burden on Coated Flow Diverters Assessed by High Frequency Optical Coherence Tomography.</name><description>&lt;h4>Purpose&lt;/h4>The implantation of flow diverters requires administration of dual anti-platelet therapy, posing the potential for complications. The p48MW HPC (phenox, Bochüm, Germany) hydrophilic-coated flow diverting stent is designed to be anti-thrombotic, thus opening the potential for single anti-platelet therapy. We deploy a novel intravascular high-resolution imaging technique, high-frequency optical coherence tomography (HF-OCT), to study in an animal model the acute thrombus formation on coated p48MW devices versus uncoated control devices.&lt;h4>Methods&lt;/h4>Three pigs were implanted with 4 flow diverters each, two test hydrophilic-coated devices, and two control uncoated devices (p48MW). Each pig was treated with a different anti-platelet regime: no anti-platelet therapy, aspirin only, aspirin and clopidogrel. Twenty minutes after the flow diverter was implanted, an HF-OCT data set was acquired. Acute clot formed on the flow diverter at each covered side branch was measured from the HF-OCT slices. Factors considered to be important were the device type (pHPC versus bare metal), aspirin, clopidogrel, and vessel location. A linear model was constructed from the significant factors.&lt;h4>Results&lt;/h4>Both coating (p &lt; 0.001) and aspirin (p = 0.003) were significantly related to reduction in clot burden, leading to an approximate 100-fold and 50-fold reduction in clot, respectively.&lt;h4>Conclusions&lt;/h4>This study shows the power of HF-OCT not only in the detection of clot but also the quantification of clot burden. In an animal model, the pHPC-coated p48MW significantly reduced acute thrombus formation over jailed side branches as compared to the bare metal p48MW that was nearly eliminated when combined with aspirin administration.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Aug</publication><modification>2024-12-04T11:30:39.282Z</modification><creation>2022-02-11T01:08:35.574Z</creation></dates><accession>S-EPMC8209672</accession><cross_references><pubmed>32385610</pubmed><doi>10.1007/s00270-020-02482-w</doi></cross_references></HashMap>